Page 338 - Binder2
P. 338

This model introduces something almost foreign to
               traditional pharma:

               Built-in redundancy—with minimal cost.




               How It Works


               With proper process controls and digital traceability—
               tracking plant lineage, gene construct, growth parameters,
               and batch harvesting—multiple grow sites can produce
               the same therapeutic product simultaneously.


               This model allows for:




































                                          336
   333   334   335   336   337   338   339   340   341   342   343